Cetrorelix — CareFirst (Caremark)
Inhibition of premature LH surges in members undergoing ovulation induction or assisted reproductive technology (ART)
Initial criteria
- Member is undergoing ovulation induction or assisted reproductive technology (ART) for the inhibition of premature LH surges
Reauthorization criteria
- Member must continue to meet the requirements in the coverage criteria section
Approval duration
12 months